ARCHIVES

Clinical Trials: ECOG Says Results In Metastatic disease equivalent, Unlikely To change Over Time

This article is from The Cancer Letter archive.

Vol. 25 No. 15 | April 16, 1999

Download PDF Visit The Full Archive

Related Articles

DCE Board Approve Concepts For Contract Recompetitions

November 23, 1984

FDA: Silicone Breast Implants Safe, But Not “Lifetime Device”

June 24, 2011

NIH Carcinogen Guidelines Offered

April 24, 1981

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

January 31, 2003

ACS Funds Pilot Study Of Mammography Trial

July 28, 1995

Clinton Budget Provides 4.7% Increase For NIH; $118 Million Raise for NCI

February 11, 1994